PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
08-Dec-2023 Ariceum Therapeutics announces granting of US and Canadian patents for its Gallium-68 radiopharmaceutical production kit Ariceum Therapeutics
05-Dec-2023 Obulytix is developing a revolutionary solution for antibiotic resistance Obulytix
05-Dec-2023 BRAIN SCAN TECHNOLOGY TAKES A MAJOR STEP FORWARD Wideblue
05-Dec-2023 Thermosome Appoints Dr. Frank Hermann, MD, as Chief Medical Officer and Adds Prof. Alessandro Gronchi, MD, to Clinical Advisory Board Thermosome GmbH
04-Dec-2023 EBViously Presents Novel In-Vitro Data Demonstrating Potent Infection Prevention of its Vaccine Candidate EBV-001 EBViously GmbH
30-Nov-2023 PHARMANOVIA STRENGTHENS MEDICAL AFFAIRS TEAM WITH KEY APPOINTMENTS TO SUPPORT GLOBAL GROWTH Pharmanovia
29-Nov-2023 Acrometa Posts Record Revenue of S$69.5 Million for FY2023, Continues to Pursue New Opportunities in Co-Working Lab Space Business AcroMeta Group Limited
29-Nov-2023 CD Genomics Unveils Cutting-Edge 5mC/5hmC Sequencing Service to Drive Epigenomics Research Forward CD Genomics
29-Nov-2023 CD Genomics Launches Full-Length 16S/18S/ITS Amplicon Sequencing Service CD Genomics
29-Nov-2023 CD Genomics Takes Genomic Research to New Heights with Ribo-seq Technology CD Genomics
29-Nov-2023 Alfa Chemistry's New Synthetic Fibers: Carbon, Ceramic, Glass, and Polymer Fibers for Advanced Applications Alfa Chemistry
29-Nov-2023 Alfa Chemistry Announces Latest Additions to Micro and Nanoelectronics Product Range: CVD and ALD Precursors and Beyond Alfa Chemistry
28-Nov-2023 Enhanced Potential of Myricx’s NMT Inhibitor Payloads with Dual Senolytic and Cytotoxic Modes of Action as ADC Cancer Therapies Myricx Bio
28-Nov-2023 Highly experienced CDMO expert Michel Spagnol appointed Chairman of Astraveus Astraveus SAS
28-Nov-2023 Harness Therapeutics secures additional £4 million funding to pursue physiological upregulation approach to treat neurodegenerative diseases Harness Therapeutics
28-Nov-2023 NICE endorses only approved treatment for ultra-rare Wolman disease for children diagnosed under the age of two: Interview Opportunity National Institute for Health and Care Excellence (NICE)
28-Nov-2023 Priothera – US FDA grants Orphan Drug Designation to mocravimod to improve the outcome of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with hematologic malignancies Priothera Ltd
28-Nov-2023 National call for volunteers to test ground-breaking psychedelic treatments for mental health conditions Clerkenwell Health
28-Nov-2023 Scientists harness flower “super power” to pave the way for new drug treatments University of Bath
28-Nov-2023 ACG showcases a concept of a next generation capsule filling machine- AF330 at CPHI and PMEC 2023 ACG